Tacita Capital Inc Vaccinex, Inc. Transaction History

Tacita Capital Inc

  • $138 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022
SELL
$1.04 - $2.12 $14,116 - $28,776
-13,574 Closed
0 $0
Q4 2020

Feb 17, 2021
BUY
$1.66 - $2.35 $22,532 - $31,898
13,574 New
13,574 $28,000

Others Institutions Holding VCNX

# of Institutions
2
Shares Held
426K
Call Options Held
0
Put Options Held
0
View Full List

About VACCINEX, INC.

VCNX Quotes by TradingView
  • Ticker VCNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,664,100
  • Market Cap $154M
  • Description
  • Vaccinex, Inc., a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs. The company offers its products for the treatment of cancer, neurodegenerative diseases, and autoimmune disorders. Its lead product candidate is pepinemab,...
More about VCNX
Track This Portfolio

Track Tacita Capital Inc Portfolio

Follow Tacita Capital Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tacita Capital Inc, based on Form 13F filings with the SEC.

News

Stay updated on Tacita Capital Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email